final analysis of the atlantis cabozantinib comparison
Published 2 years ago • 334 plays • Length 7:08Download video MP4
Download video MP3
Similar videos
-
2:19
final results from atlantis cabozantinib arm for urothelial carcinoma
-
1:12
cabozantinib for advanced renal cell carcinoma: the meteor and cabosun trials
-
4:09
subgroup analyses of meteor; randomized phase iii trial of cabozantinib vs everolimus for rcc
-
6:26
esmo 2016: press brief on results of cabosun trial cabozantinib compared to sunitinib in rcc
-
0:49
dr. apolo on side effects of cabozantinib plus immunotherapy agents in bladder cancer
-
6:30
cabozantinib: the meteor trial
-
0:54
interim results from arcadia trial: cabozantinib plus durvalumab in advanced urothelial carcinoma
-
0:55
dr. apolo on the combination of cabozantinib plus nivolumab in urothelial carcinoma
-
1:40
phase iii meteor trial: cabozantinib vs everolimus for advanced clear cell renal cell carcinoma
-
5:08
cabosun trial of upfront cabozantinib in metastatic rcc
-
2:05
esmo 2020 highlights on nivolumab cabozantinib as 1st line therapy for arcc: the checkmate 9er study
-
1:13
dr. apolo on the safety of nivolumab plus cabozantinib in urothelial carcinoma
-
8:40
advanced hcc: celestial trial
-
1:43
understanding variant histologies in urothelial carcinoma: io and cabozantinib's potential
-
0:57
exploring cabozantinib with nivolumab and ipilimumab in urothelial carcinoma
-
7:29
results from cabosun, meteor and javelin
-
1:04
dr. wei on the use of cabozantinib in advanced kidney cancer
-
5:42
meteor trial: cabozantinib vs everolimus in advanced renal cell carcinoma
-
0:50
maintenance therapy for patients with advanced urothelial carcinoma